Wednesday, September 7, 2011

Dynavax lands $600K SBIR grant for autoimmune inflammation study

Dynavax Technologies Corp. got a two-year grant of $600,000 for the study of autoimmune inflammation.
Berkeley-based Dynavax (NASDAQ: DVAX) got the money as a Small Business Innovation Research, or SBIR, grant. The National Institute of Allergy and Infectious Diseases gave the money.

No comments:

Post a Comment